The AHA is hosting calls for all hospital and health system leaders to provide the latest information on and answer questions about the COVID-19 pandemic. The next call is July 9 from 2:30-3:45 p.m. ET. Food and Drug Administration Commissioner Stephen Hahn, M.D., will address FDA’s response to the COVID-19 epidemic, including emergency use authorizations, remdesivir distribution and vaccine clinical trials. 

In addition, AHA Board Chair Melinda Estes, M.D., AHA President and CEO Rick Pollack and AHA senior leaders will give updates on advocacy, regulatory and policy developments, as well as the association’s efforts to support members in their efforts to combat COVID-19. 

Callers are encouraged to dial in at least 10-15 minutes in advance. Please dial 800-469-8538 and enter the participant passcode 43576#.

Related News Articles

Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…